Think Bioscience: Pioneering the Hunt for Drug Therapies
May 11, 2024, 3:37 am
Think Bioscience Inc. is making waves in the biotech world with their innovative approach to developing small-molecule therapeutics that target "undruggable" proteins. With a recent $26 million seed round, including a $6 million expansion, the company is on a mission to find new "pockets" for drug therapies.
Think Bioscience's unique pocket-finding process involves programming microbes to build small molecules that bind to functional pockets on protein targets. These pockets are like hidden treasures, waiting to be discovered and unlocked for potential drug therapies. By expanding their platform technology to a variety of targets such as protein tyrosine phosphatases, kinases, proteases, and GTPases, Think Bioscience is paving the way for groundbreaking treatments.
Led by CEO Jerome Fox, the company is redefining synthetic biology by harnessing the power of living systems to guide the design and assembly of medicines. Dr. Wendy Young, a seasoned veteran in the biopharma industry, has joined the Board of Directors, bringing her wealth of experience to the table. With a team of experts like Dr. Young and fellow drug developer Nick Saccomano, Think Bioscience is well-equipped to accelerate their pipeline and bring new therapies to market.
Nature has bestowed living systems with the ability to create potent bioactive compounds, and Think Bioscience is tapping into this natural selection process to discover new functional pockets on challenging drug targets. These pockets are like gold mines, holding the key to unlocking the next generation of life-saving treatments.
In a world where finding new drug targets is like searching for a needle in a haystack, Think Bioscience is leading the charge in uncovering these elusive pockets and turning them into opportunities for therapeutic breakthroughs. With their cutting-edge technology and team of industry experts, the company is poised to make a significant impact in the field of biotech and revolutionize the way we approach drug discovery.
Think Bioscience's commitment to innovation and dedication to finding new solutions for unmet medical needs sets them apart as a trailblazer in the biotech industry. As they continue to push the boundaries of what is possible in drug development, the future looks bright for Think Bioscience and the patients who stand to benefit from their groundbreaking work.
Think Bioscience's unique pocket-finding process involves programming microbes to build small molecules that bind to functional pockets on protein targets. These pockets are like hidden treasures, waiting to be discovered and unlocked for potential drug therapies. By expanding their platform technology to a variety of targets such as protein tyrosine phosphatases, kinases, proteases, and GTPases, Think Bioscience is paving the way for groundbreaking treatments.
Led by CEO Jerome Fox, the company is redefining synthetic biology by harnessing the power of living systems to guide the design and assembly of medicines. Dr. Wendy Young, a seasoned veteran in the biopharma industry, has joined the Board of Directors, bringing her wealth of experience to the table. With a team of experts like Dr. Young and fellow drug developer Nick Saccomano, Think Bioscience is well-equipped to accelerate their pipeline and bring new therapies to market.
Nature has bestowed living systems with the ability to create potent bioactive compounds, and Think Bioscience is tapping into this natural selection process to discover new functional pockets on challenging drug targets. These pockets are like gold mines, holding the key to unlocking the next generation of life-saving treatments.
In a world where finding new drug targets is like searching for a needle in a haystack, Think Bioscience is leading the charge in uncovering these elusive pockets and turning them into opportunities for therapeutic breakthroughs. With their cutting-edge technology and team of industry experts, the company is poised to make a significant impact in the field of biotech and revolutionize the way we approach drug discovery.
Think Bioscience's commitment to innovation and dedication to finding new solutions for unmet medical needs sets them apart as a trailblazer in the biotech industry. As they continue to push the boundaries of what is possible in drug development, the future looks bright for Think Bioscience and the patients who stand to benefit from their groundbreaking work.